+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 55Years +
MALE
ID07856017

Exploring an Intelligent MRI-Based System for Prostate Cancer Biopsy Guidance Using Real-Time Metabolic Feedback

Led by Shanghai Zhongshan Hospital · Updated on 2026-10-02

90

Participants Needed

4

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to develop an intelligent system that combines preoperative imaging and real-time metabolic feedback during surgery to optimize biopsy core placement for prostate cancer diagnosis. It focuses on improving precision in sampling using advanced imaging and metabolic data integration. The study is exploratory and observational, targeting men with prostate cancer indications to enhance biopsy accuracy. Participants undergo one of three biopsy methods an adaptive dynamic biopsy using the intelligent system integrating imaging and metabolic feedback, a standard 10-12-core systematic biopsy, or a multiparametric MRI-ultrasound fusion-guided targeted prostate biopsy. These methods are compared to evaluate which approach requires fewer biopsy cores and achieves better diagnostic results. During the study, participants will have their prostate-specific antigen levels and multiparametric MRI results reviewed. Researchers will monitor the number of biopsy cores needed to confirm diagnosis, cancer detection rates, missed diagnosis rates, biopsy duration, and complication rates. Outcomes are assessed after eight weeks from enrollment completion, providing insight into biopsy effectiveness and safety.

CONDITIONS

Brief Title

Development of an Intraoperative Adaptive Biopsy System for Prostate Cancer: Integrating Imaging Navigation With Metabolic Feedback for Dynamic Decision-Making

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here